WIRB-Copernicus Group has acquired ThreeWire, the global patient recruitment, enrollment, and retention firm.
Having screened over two million patients in more than 25 countries, ThreeWire’s approach produces measurable, predictable results for its U.S. and overseas clients.
“We continue to invest in technologies and services that offer a unique approach to improving the quality and efficiency of clinical research, while ensuring patient safety,” Donald A. Deieso, Ph.D., chairman and CEO of WCG said. “ThreeWire expands our portfolio of services to identify and connect patient candidates to clinical sites and meaningfully accelerate patient recruitment and enrollment, potentially saving sponsors millions of dollars.”
ThreeWire combines technology with on-the-ground resources to help investigators recruit and conduct clinical studies. The company’s 300+ global, clinical research professionals work at study sites to close staffing and other resource gaps at those sites. They also provide on-site recruitment services such as reviewing the sites’ patient charts to identify study candidates and conducting local community outreach to patient groups and referral physicians.
ThreeWire will continue to operate as an independent organization. ThreeWire clients can continue to expect the same dedication to quality customer service. WCG will support ThreeWire as it continues to expand, with access to capital, complementary clinical and regulatory expertise, and corporate support.